| FDA approves add-on therapy to lower cholesterol among certain high-risk adults |
12/22/2021 |
Leqvio |
inclisiran |
| FDA approves drug to treat, help prevent types of blood clots in certain pediatric populations |
12/20/2021 |
Xarelto |
rivaroxaban |
| FDA approves Tezspire as maintenance treatment for severe asthma |
12/17/2021 |
Tezspire |
tezepelumab-ekko |
| FDA approves drug to treat sickle cell disease in patients aged 4 up to 11 years |
12/17/2021 |
Oxbryta |
voxelotor |
| FDA approves first drug to decrease urine protein in IgA nephropathy, a rare kidney disease |
12/15/2021 |
Tarpeyo |
budesonide |
| FDA approves naloxone injection to counteract opioid overdoses |
10/15/2021 |
ZIMHI |
naloxone hydrochloride |
| FDA approves add-on drug for adults with rare form of blood vessel inflammation |
10/13/2021 |
Tavneos |
avacopan |
| FDA approves add-on drug for ages 10 & up with rare forms of high cholesterol |
9/24/2021 |
Repatha |
evolocumab |
| FDA approves new use of transplant drug based on real-world evidence |
7/16/2021 |
Prograf |
tacrolimus |
| FDA approves drug to reduce risk of serious kidney and heart complications in adults with chronic kidney disease associated with type 2 diabetes |
7/9/2021 |
Kerendia |
finerenone |
| FDA approves therapy for pediatric patients with serious rare blood disease |
6/7/2021 |
Ultomiris |
ravulizumab-cwvz |
| FDA approves drug to treat smallpox |
6/4/2021 |
Tembexa |
brincidofovir |
| FDA approves second PSMA-targeted PET imaging drug for men with prostate cancer |
5/27/2021 |
Pylarify |
piflufolastat F 18 |
| FDA approves new treatment for adults with serious rare blood disease |
5/14/021 |
Empaveli |
pegcetacoplan |
| FDA approves add-on therapy for patients with genetic form of severely high cholesterol |
4/1/2021 |
Praluent |
alirocumab |
| FDA approves first treatment for disease that causes recurrent inflammation in sac surrounding heart |
3/18/2021 |
Arcalyst |
rilonacept |
| FDA approves add-on therapy for patients with genetic form of severely high cholesterol |
2/11/2021 |
Evkeeza |
evinacumab-dgnb |
| FDA approves treatment for ebola virus |
12/21/2020 |
Ebanga |
Ansuvimab-zykl |
| FDA approves weight management drug for patients aged 12 and older |
12/4/2020 |
Saxenda |
liraglutide |
| FDA approves first treatment for weight management for people with certain rare genetic conditions |
11/27/2020 |
Imcivree |
setmelanotide |
| FDA’s approval of Veklury (remdesivir) for the treatment of COVID-19—the science of safety and effectiveness |
10/22/2020 |
Veklury |
remdesivir |
| FDA approves weekly therapy for adult growth hormone deficiency |
9/1/2020 |
Sogroya |
somapacitan |
| FDA approves new treatment for rare hereditary disease |
8/23/2018 |
Takhzyro |
lanadelumab |
